{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:18:04Z","timestamp":1785842284905,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Second Century Fund Chulalongkorn University","award":["1918\/2563"],"award-info":[{"award-number":["1918\/2563"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Demographic features, suggestive gynaecological symptoms, and immunohistochemical expression of endometrial \u03b2-catenin have a prognostic capacity for endometrial hyperplasia and carcinoma. This study assessed the interaction of all variables and developed risk stratification for endometrial hyperplasia and carcinoma.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This cross-sectional study was conducted from January 2023 to July 2023 at two teaching hospitals in Makassar Indonesia. Patients (&lt;\u200970 years old) with suggestive symptoms of endometrial hyperplasia or carcinoma or being referred with disease code N.85 who underwent curettage and\/or surgery for pathology assessment except those receiving radiotherapy, or chemotherapy, presence of another carcinoma, coagulation disorder, and history of anti-inflammatory drug use and unreadable samples. Demographic, and clinical symptoms were collected from medical records. Immunohistochemistry staining using mouse-monoclonal antibodies determined the \u03b2-catenin expression (percentage, intensity, and H-score) in endometrial tissues. Ordinal and Binary Logistic regression identified the potential predictors to be included in neural networks and decision tree models of histopathological grading according to the World Health Organization\/WHO grading classification.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Abdominal enlargement was associated with worse pathological grading (adjusted odds ratio\/aOR 6.7 95% CI 1.8\u201324.8). Increasing age (aOR 1.1 95% CI 1.03\u20131.2) and uterus bleeding (aOR 5.3 95% CI 1.3\u201321.6) were associated with carcinoma but not with %\u03b2-catenin and H-Score. However, adjusted by vaginal bleeding and body mass index, lower %\u03b2-catenin (aOR 1.03 95% 1.01\u20131.05) was associated with non-atypical hyperplasia, as well as H-Score (aOR 1.01 95% CI 1.01\u20131.02). Neural networks and Decision tree risk stratification showed a sensitivity of 80-94.8% and a specificity of 40.6\u201360% in differentiating non-atypical from atypical and carcinoma. A cutoff of 55% \u03b2-catenin area and H-Score of 110, along with other predictors could distinguish non-atypical samples from atypical and carcinoma.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Risk stratification based on demographics, clinical symptoms, and \u03b2-catenin possesses a good performance in differentiating non-atypical hyperplasia with later stages.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02790-6","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T04:12:09Z","timestamp":1701058329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk-stratification machine learning model using demographic factors, gynaecological symptoms and \u03b2-catenin for endometrial hyperplasia and carcinoma: a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Rina","family":"Masadah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aries","family":"Maulana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berti Julian","family":"Nelwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmud","family":"Ghaznawie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upik Anderiani","family":"Miskad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryani","family":"Tawali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syahrul","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumi","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"issue":"12","key":"2790_CR1","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1002\/1097-0142(19820615)49:12<2547::AID-CNCR2820491224>3.0.CO;2-0","volume":"49","author":"RJ Kurman","year":"1982","unstructured":"Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer. 1982;49(12):2547\u201359.","journal-title":"Cancer"},{"issue":"4","key":"2790_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/cncr.21650","volume":"106","author":"CL Trimble","year":"2006","unstructured":"Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ 2, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106(4):812\u20139.","journal-title":"Cancer"},{"issue":"6","key":"2790_CR3","first-page":"468","volume":"93","author":"MM Braun","year":"2016","unstructured":"Braun MM, Overbeek-Wager EA, Grumbo RJ. Diagnosis and management of Endometrial Cancer. Am Fam Physician. 2016;93(6):468\u201374.","journal-title":"Am Fam Physician"},{"issue":"12","key":"2790_CR4","doi-asserted-by":"publisher","first-page":"e0243064","DOI":"10.1371\/journal.pone.0243064","volume":"15","author":"JY Jeong","year":"2020","unstructured":"Jeong JY, Hwang SO, Lee B, Kim K, Kim YB, Park SH, et al. Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: a retrospective cohort study. PLoS ONE. 2020;15(12):e0243064.","journal-title":"PLoS ONE"},{"issue":"1","key":"2790_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ygyno.2020.10.033","volume":"160","author":"AM Rodriguez","year":"2021","unstructured":"Rodriguez AM, Polychronopoulou E, Hsu E, Shah R, Lamiman K, Kuo YF. Factors associated with endometrial cancer and hyperplasia among middle-aged and older hispanics. Gynecol Oncol. 2021;160(1):16\u201323.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2790_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12905-021-01452-9","volume":"21","author":"J Zhao","year":"2021","unstructured":"Zhao J, Hu Y, Zhao Y, Chen D, Fang T, Ding M. Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments. BMC Womens Health. 2021;21(1):312.","journal-title":"BMC Womens Health"},{"issue":"7","key":"2790_CR7","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ijc.31961","volume":"145","author":"O Raglan","year":"2019","unstructured":"Raglan O, Kalliala I, Markozannes G, Cividini S, Gunter MJ, Nautiyal J, et al. Risk factors for endometrial cancer: an umbrella review of the literature. Int J Cancer. 2019;145(7):1719\u201330.","journal-title":"Int J Cancer"},{"issue":"11","key":"2790_CR8","doi-asserted-by":"publisher","first-page":"e05372","DOI":"10.1016\/j.heliyon.2020.e05372","volume":"6","author":"S Boeckstaens","year":"2020","unstructured":"Boeckstaens S, Dewalheyns S, Heremans R, Vikram R, Timmerman D, Van den Bosch T, et al. Signs and symptoms associated with Uterine cancer in pre- and postmenopausal women. Heliyon. 2020;6(11):e05372.","journal-title":"Heliyon"},{"key":"2790_CR9","doi-asserted-by":"publisher","first-page":"567305","DOI":"10.1155\/2011\/567305","volume":"2011","author":"X Tian","year":"2011","unstructured":"Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR, et al. E-cadherin\/\u03b2-catenin complex and the epithelial barrier. J Biomed Biotechnol. 2011;2011:567305.","journal-title":"J Biomed Biotechnol"},{"key":"2790_CR10","doi-asserted-by":"publisher","first-page":"1009345","DOI":"10.3389\/fonc.2022.1009345","volume":"12","author":"ML Parrish","year":"2022","unstructured":"Parrish ML, Broaddus RR, Gladden AB. Mechanisms of mutant \u03b2-catenin in endometrial cancer progression. Front Oncol. 2022;12:1009345.","journal-title":"Front Oncol"},{"issue":"1","key":"2790_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/modpathol.2013.107","volume":"27","author":"MK McConechy","year":"2014","unstructured":"McConechy MK, Ding J, Senz J, Yang W, Melnyk N, Tone AA, et al. Ovarian and endometrial endometrioid carcinomas have distinct < em > CTNNB1 and < em > PTEN mutation profiles. Mod Pathol. 2014;27(1):128\u201334.","journal-title":"Mod Pathol"},{"issue":"10","key":"2790_CR12","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/01.MP.0000028573.34289.04","volume":"15","author":"PW Schlosshauer","year":"2002","unstructured":"Schlosshauer PW, Ellenson LH, Soslow RA. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype. Mod Pathol. 2002;15(10):1032\u20137.","journal-title":"Mod Pathol"},{"issue":"1","key":"2790_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/onc.2008.363","volume":"28","author":"JW Jeong","year":"2009","unstructured":"Jeong JW, Lee HS, Franco HL, Broaddus RR, Taketo MM, Tsai SY, et al. beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus. Oncogene. 2009;28(1):31\u201340.","journal-title":"Oncogene"},{"issue":"5","key":"2790_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/ajcp\/aqy178","volume":"151","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G, De Luca C, Mollo A, Mascolo M, et al. Immunohistochemical nuclear expression of \u03b2-Catenin as a Surrogate of CTNNB1 exon 3 mutation in Endometrial Cancer. Am J Clin Pathol. 2019;151(5):529\u201338.","journal-title":"Am J Clin Pathol"},{"key":"2790_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-59745-249-6_7","volume-title":"Wnt signaling: pathway methods and mammalian models","author":"N Barker","year":"2008","unstructured":"Barker N, Born M. Detection of \u03b2-Catenin localization by immunohistochemistry. In: Vincan E, editor. Wnt signaling: pathway methods and mammalian models. Totowa, NJ: Humana Press; 2008. pp. 91\u20138."},{"issue":"6","key":"2790_CR16","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/modpathol.2008.53","volume":"21","author":"C-K Jung","year":"2008","unstructured":"Jung C-K, Jung J-H, Lee A, Lee Y-S, Choi Y-J, Yoon S-K, et al. Diagnostic use of nuclear \u03b2-catenin expression for the assessment of endometrial stromal tumors. Mod Pathol. 2008;21(6):756\u201363.","journal-title":"Mod Pathol"},{"key":"2790_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5114\/pm.2017.70589","volume":"16","author":"K Sobczuk","year":"2017","unstructured":"Sobczuk K, Sobczuk A. New classification system of endometrial hyperplasia WHO 2014 and its clinical implications. Przeglad Menopauzalny = Menopause Review. 2017;16:107\u201311.","journal-title":"Przeglad Menopauzalny = Menopause Review"},{"issue":"11","key":"2790_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/apm.12988","volume":"127","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G, Mascolo M, D\u2019Alessandro P, Arduino B, et al. Nuclear expression of \u03b2-catenin in endometrial hyperplasia as marker of premalignancy. APMIS. 2019;127(11):699\u2013709.","journal-title":"APMIS"},{"issue":"3","key":"2790_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/aogs.14015","volume":"100","author":"N Hag-Yahia","year":"2021","unstructured":"Hag-Yahia N, Gemer O, Eitan R, Raban O, Vaknin Z, Levy T, et al. Age is an Independent predictor of outcome in endometrial cancer patients: an Israeli Gynecology Oncology Group cohort study. Acta Obstet Gynecol Scand. 2021;100(3):444\u201352.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"2790_CR20","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/1471-0528.17087","volume":"129","author":"M Dalmartello","year":"2022","unstructured":"Dalmartello M, Vermunt J, Negri E, Levi F, La Vecchia C. Adult lifetime body mass index trajectories and endometrial cancer risk. BJOG. 2022;129(9):1521\u20139.","journal-title":"BJOG"},{"key":"2790_CR21","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3389\/fphys.2018.00792","volume":"9","author":"N Chen","year":"2018","unstructured":"Chen N, Wang J. Wnt\/\u03b2-Catenin signaling and obesity. Front Physiol. 2018;9:792.","journal-title":"Front Physiol"},{"issue":"2","key":"2790_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/humupd\/dmu053","volume":"21","author":"DK Hapangama","year":"2015","unstructured":"Hapangama DK, Kamal AM, Bulmer JN. Estrogen receptor \u03b2: the guardian of the endometrium. Hum Reprod Update. 2015;21(2):174\u201393.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2790_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1530\/REP-15-0371","volume":"150","author":"W Xiong","year":"2015","unstructured":"Xiong W, Zhang L, Yu L, Xie W, Man Y, Xiong Y, et al. Estradiol promotes cells invasion by activating \u03b2-catenin signaling pathway in endometriosis. Reproduction. 2015;150(6):507\u201316.","journal-title":"Reproduction"},{"issue":"5","key":"2790_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/10668969211065110","volume":"30","author":"P Chatzipantelis","year":"2022","unstructured":"Chatzipantelis P, Koukourakis M, Balaska K, Giatromanolaki A. Endometrial stromal expression of ER, PR, and B-Catenin toward differentiating Hyperplasia Diagnoses. Int J Surg Pathol. 2022;30(5):492\u20138.","journal-title":"Int J Surg Pathol"},{"issue":"11","key":"2790_CR25","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1089\/jwh.2015.5657","volume":"25","author":"Endometrial Cancer Associated Symptoms","year":"2016","unstructured":"Endometrial Cancer Associated Symptoms. A case-control study. J Women\u2019s Health. 2016;25(11):1187\u201392.","journal-title":"J Women\u2019s Health"},{"issue":"1","key":"2790_CR26","doi-asserted-by":"publisher","first-page":"14243","DOI":"10.1038\/srep14243","volume":"5","author":"Q-J Wu","year":"2015","unstructured":"Wu Q-J, Li Y-Y, Tu C, Zhu J, Qian K-Q, Feng T-B, et al. Parity and endometrial cancer risk: a meta-analysis of epidemiological studies. Sci Rep. 2015;5(1):14243.","journal-title":"Sci Rep"},{"issue":"3","key":"2790_CR27","doi-asserted-by":"publisher","first-page":"e0249243","DOI":"10.1371\/journal.pone.0249243","volume":"16","author":"B Herman","year":"2021","unstructured":"Herman B, Sirichokchatchawan W, Pongpanich S, Nantasenamat C. Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance Tuberculosis screening in Indonesia. PLoS ONE. 2021;16(3):e0249243.","journal-title":"PLoS ONE"},{"key":"2790_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fonc.2020.00056","volume":"10","author":"L Deng","year":"2020","unstructured":"Deng L, Liang H, Han Y. Cyclooxygenase-2 and \u03b2-Catenin as potential diagnostic and prognostic markers in Endometrial Cancer. Front Oncol. 2020;10:56.","journal-title":"Front Oncol"},{"issue":"7","key":"2790_CR29","doi-asserted-by":"publisher","first-page":"674","DOI":"10.18632\/oncotarget.201","volume":"1","author":"Y Wang","year":"2010","unstructured":"Wang Y, van der Zee M, Fodde R, Blok LJ. Wnt\/\u0392-catenin and sex hormone signaling in endometrial homeostasis and cancer. Oncotarget. 2010;1(7):674\u201384.","journal-title":"Oncotarget"},{"issue":"4","key":"2790_CR30","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1210\/jc.2005-0769","volume":"91","author":"S Tulac","year":"2006","unstructured":"Tulac S, Overgaard MT, Hamilton AE, Jumbe NL, Suchanek E, Giudice LC. Dickkopf-1, an inhibitor of wnt signaling, is regulated by progesterone in human endometrial stromal cells. J Clin Endocrinol Metab. 2006;91(4):1453\u201361.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2790_CR31","doi-asserted-by":"publisher","first-page":"357.e1","DOI":"10.1016\/j.ajog.2010.12.007","volume":"204","author":"A Steinbakk","year":"2011","unstructured":"Steinbakk A, Gudlaugsson E, Aasprong OG, Skaland I, Malpica A, Feng W, et al. Molecular biomarkers in endometrial hyperplasias predict cancer progression. Am J Obstet Gynecol. 2011;204(4):357 e1\u2013.e12.","journal-title":"Am J Obstet Gynecol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02790-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T04:12:22Z","timestamp":1701058342000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02790-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2790"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02790-6","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"5 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is part of clinical trials registered with number NCT05697601 with the number of Institutional Review Board (IRB) Full Board of Faculty of Medicine Hasanuddin University approval number 800\/UN4.6.4.5.31\/PP36\/2022. Patients were not purposively recruited for the research but for diagnosis and treatment. However, the patients acknowledged that the use of biological samples taken for pathology assessment would be used for research purposes and written consent was given by the individual at the beginning of patient admission. The procedure that was performed in this study did not affect the patients directly, and should the diagnostic finding require immediate care, referral for treatment would be performed accordingly. All data used in this study was anonymized \/ de-identified to ensure the confidentiality of the information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As the data was part of a routine medical procedure, the hospital also gave consent in a statement as follows, \u201cAs our hospital is one of the centres for medical education, in certain parts of your care, there will be an involvement of students who are equipped with sufficient clinical knowledge to observe and perform medical procedures and further examination when deemed necessary. Moreover, our hospital also serves as a clinical research unit that will employ and utilise the data stored in the medical record for medical training and research. This is in line with the Health Ministerial Regulation number 269 year 2008 regarding medical records\u2026\u201d. The aforementioned IRB also granted the waiver for additional informed consent following the regulation by the Ministry of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"One author (BH) received funding from The Second Century Fund Chulalongkorn University Thailand for work on the research topic falling under Medicine and Public Health Topic for the Thai Society. No conflict of interest exists for the remaining authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"627"}}